|
US7129390B2
(en)
*
|
1997-10-16 |
2006-10-31 |
Avigenics, Inc |
Poultry Derived Glycosylated Interferon Alpha 2b
|
|
US20050181482A1
(en)
*
|
2004-02-12 |
2005-08-18 |
Meade Harry M. |
Method for the production of an erythropoietin analog-human IgG fusion proteins in transgenic mammal milk
|
|
WO1999066054A2
(en)
*
|
1998-06-15 |
1999-12-23 |
Genzyme Transgenics Corp. |
Erythropoietin analog-human serum albumin fusion protein
|
|
US20030005468A1
(en)
*
|
1998-06-19 |
2003-01-02 |
Meade Harry M. |
Methods and vectors for improving nucleic acid expression
|
|
GB9817084D0
(en)
*
|
1998-08-06 |
1998-10-07 |
Wood Christopher B |
A method for promoting extra-heptic production of proteins for the correction of hypoalbuminaemia,anaemia,thrombocytopenia and/or coagulation disorders
|
|
US7304150B1
(en)
*
|
1998-10-23 |
2007-12-04 |
Amgen Inc. |
Methods and compositions for the prevention and treatment of anemia
|
|
US7087411B2
(en)
|
1999-06-08 |
2006-08-08 |
Regeneron Pharmaceuticals, Inc. |
Fusion protein capable of binding VEGF
|
|
EP1237900A4
(de)
*
|
1999-09-17 |
2005-08-03 |
Gtc Biotherapeutics Inc |
Durch untereinheiten optimierte fusionsproteine
|
|
JP2003514552A
(ja)
*
|
1999-11-12 |
2003-04-22 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
改善された性質を有するエリトロポエチンの形態
|
|
US6926898B2
(en)
|
2000-04-12 |
2005-08-09 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
US20040226053A1
(en)
*
|
2000-10-13 |
2004-11-11 |
Meade Harry M. |
Methods of producing a target molecule in a transgenic animal and purification of the target molecule
|
|
KR20080085082A
(ko)
*
|
2000-12-07 |
2008-09-22 |
일라이 릴리 앤드 캄파니 |
Ｇｌｐ-1 융합 단백질
|
|
WO2002064085A2
(en)
|
2001-02-02 |
2002-08-22 |
Ortho-Mcneil Pharmaceutical, Inc. |
Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin
|
|
WO2002079415A2
(en)
|
2001-03-30 |
2002-10-10 |
Lexigen Pharmaceuticals Corp. |
Reducing the immunogenicity of fusion proteins
|
|
WO2003030821A2
(en)
*
|
2001-10-05 |
2003-04-17 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
US6818613B2
(en)
|
2001-11-07 |
2004-11-16 |
Ortho-Mcneil Pharmaceutical, Inc. |
Aqueous sustained-release formulations of proteins
|
|
BR0214557A
(pt)
|
2001-11-28 |
2006-06-06 |
Ortho Mcneil Pharm Inc |
regime de dosagem de eritropoietina para o tratamento de anemia
|
|
ES2500918T3
(es)
*
|
2001-12-21 |
2014-10-01 |
Human Genome Sciences, Inc. |
Proteínas de fusión de albúmina e interferón beta
|
|
EP1463752A4
(de)
*
|
2001-12-21 |
2005-07-13 |
Human Genome Sciences Inc |
Albuminfusionsproteine
|
|
US7129267B2
(en)
|
2002-03-11 |
2006-10-31 |
Janssen Pharmaceutica N.V. |
Methods for SHP1 mediated neuroprotection
|
|
WO2004022593A2
(en)
*
|
2002-09-09 |
2004-03-18 |
Nautilus Biotech |
Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
|
|
US7803362B2
(en)
*
|
2003-01-24 |
2010-09-28 |
Synageva Biopharma Corp. |
Glycosylated interferon alpha
|
|
US20040198663A1
(en)
*
|
2003-04-04 |
2004-10-07 |
Baker John E. |
Method of treating cardiac ischemia by using erythropoietin
|
|
WO2004101620A2
(en)
*
|
2003-05-01 |
2004-11-25 |
Compound Therapeutics, Inc. |
Serum albumin scaffold-based proteins and uses thereof
|
|
SI1729795T1
(sl)
|
2004-02-09 |
2016-04-29 |
Human Genome Sciences, Inc. |
Albuminski fuzijski proteini
|
|
US7588745B2
(en)
*
|
2004-04-13 |
2009-09-15 |
Si Options, Llc |
Silicon-containing products
|
|
JP2008512385A
(ja)
*
|
2004-09-03 |
2008-04-24 |
アルザ コーポレイション |
アルブミンの内因的に形成された結合体
|
|
MX2008008076A
(es)
*
|
2005-12-22 |
2008-11-28 |
Conjuchem Biotechnologies Inc |
Procesos para la produccion de conjugados preformados de albumina y un agente terapeutico.
|
|
US7625564B2
(en)
|
2006-01-27 |
2009-12-01 |
Novagen Holding Corporation |
Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
|
|
EP1816201A1
(de)
*
|
2006-02-06 |
2007-08-08 |
CSL Behring GmbH |
Modifizierter Koagulationsfaktor VIIa mit verbesserter 'half-life'-Stabiltät
|
|
US7812127B2
(en)
|
2006-03-17 |
2010-10-12 |
Synageva Biopharma Corp. |
Glycosylated human G-CSF
|
|
JP2009533364A
(ja)
*
|
2006-04-11 |
2009-09-17 |
ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー |
治療用ポリペプチドのインビボでの回収を増大させる方法
|
|
CN101062407A
(zh)
|
2006-04-29 |
2007-10-31 |
中国科学院上海生命科学研究院 |
促红细胞生成素在预防或治疗视网膜损伤中的用途
|
|
EP2474318A1
(de)
|
2006-06-07 |
2012-07-11 |
Human Genome Sciences, Inc. |
Albumin-Fusionsproteine
|
|
US7939632B2
(en)
*
|
2006-06-14 |
2011-05-10 |
Csl Behring Gmbh |
Proteolytically cleavable fusion proteins with high molar specific activity
|
|
KR20090060294A
(ko)
|
2006-09-08 |
2009-06-11 |
암브룩스, 인코포레이티드 |
변형된 인간 혈장 폴리펩티드 또는 Ｆｃ 스캐폴드 및 그의 용도
|
|
AU2007318209A1
(en)
*
|
2006-11-09 |
2008-05-15 |
Synageva Biopharma Corp |
Avian derived erythropoietin
|
|
US20090105462A1
(en)
*
|
2006-11-09 |
2009-04-23 |
Ivarie Robert D |
Glycosylated erythropoietin
|
|
WO2008056961A1
(en)
*
|
2006-11-10 |
2008-05-15 |
Boryung Pharmaceutical Co., Ltd |
A novel fusion protein, cell lines expressing the same and preparation method thereof
|
|
EP2120998B1
(de)
|
2006-11-28 |
2013-08-07 |
HanAll Biopharma Co., Ltd. |
Modifizierte erythropoetin-polypeptide und ihre verwendungen zur behandlung
|
|
WO2008077616A1
(en)
*
|
2006-12-22 |
2008-07-03 |
Csl Behring Gmbh |
Modified coagulation factors with prolonged in vivo half-life
|
|
WO2008097461A2
(en)
|
2007-02-02 |
2008-08-14 |
Amgen Inc |
Hepcidin and hepcidin antibodies
|
|
CA2720628A1
(en)
*
|
2007-07-26 |
2009-01-29 |
Novagen Holding Corporation |
Fusion proteins having mutated immunoglobulin hinge region
|
|
US20100205680A1
(en)
*
|
2007-08-08 |
2010-08-12 |
Jin Hoi Kim |
Mammary gland- specific human erytheropoietin expression vector, transgenic animal and method for producing human erythropoietin using same
|
|
CA2701032C
(en)
|
2007-09-27 |
2021-01-26 |
Amgen Inc. |
Pharmaceutical formulations
|
|
US8796206B2
(en)
|
2007-11-15 |
2014-08-05 |
Amgen Inc. |
Aqueous formulation of erythropoiesis stimulating protein stabilised by antioxidants for parenteral administration
|
|
NZ585555A
(en)
*
|
2008-01-07 |
2012-08-31 |
Synageva Biopharma Corp |
Transgenic chicken containing a transgene comprising a glycosyltransferase coding sequence
|
|
WO2009094551A1
(en)
|
2008-01-25 |
2009-07-30 |
Amgen Inc. |
Ferroportin antibodies and methods of use
|
|
CN103694337B
(zh)
|
2008-02-08 |
2016-03-02 |
Ambrx公司 |
经修饰瘦素多肽和其用途
|
|
ES2487846T3
(es)
|
2008-05-01 |
2014-08-25 |
Amgen, Inc. |
Anticuerpos anti-hepcindina y métodos de uso
|
|
US9738694B2
(en)
*
|
2008-06-30 |
2017-08-22 |
Cho-A Pharm. Co., Ltd. |
Gene of porcine alpha-s1 casein, a promoter of the same and use thereof
|
|
AU2008359017B2
(en)
*
|
2008-06-30 |
2013-01-17 |
Cho-A Pharm Co., Ltd. |
A gene of porcine beta-casein, a promoter of the same and the use thereof
|
|
KR101647164B1
(ko)
|
2008-09-26 |
2016-08-09 |
암브룩스, 인코포레이티드 |
변형된 동물 에리트로포이에틴 폴리펩티드 및 이의 용도
|
|
CN104922669A
(zh)
|
2008-11-13 |
2015-09-23 |
通用医疗公司 |
用于通过调整bmp-6来调节铁稳态的方法和组合物
|
|
US8815242B2
(en)
*
|
2009-05-27 |
2014-08-26 |
Synageva Biopharma Corp. |
Avian derived antibodies
|
|
AU2010310457B2
(en)
|
2009-10-23 |
2015-07-02 |
Amgen Inc. |
Vial adapter and system
|
|
WO2011060583A1
(zh)
|
2009-11-19 |
2011-05-26 |
浙江大学 |
非天然的胶原样蛋白及其应用
|
|
RS54291B2
(sr)
|
2010-06-07 |
2023-12-29 |
Amgen Inc |
Uređaj za isporuku lekova
|
|
JP2013535467A
(ja)
|
2010-07-28 |
2013-09-12 |
スマートセルズ・インコーポレイテツド |
組換えにより発現されたインスリンポリペプチドおよびその使用
|
|
CN112076330B
(zh)
|
2010-12-30 |
2023-06-02 |
法国化学与生物科技实验室 |
作为病原体灭活剂的二元醇
|
|
MX341790B
(es)
|
2011-03-31 |
2016-09-02 |
Amgen Inc |
Adaptador de viales y sistema.
|
|
CA3145238A1
(en)
|
2011-04-20 |
2012-10-26 |
Amgen Inc. |
Autoinjector apparatus
|
|
AR087433A1
(es)
*
|
2011-08-08 |
2014-03-26 |
Merck Sharp & Dohme |
Analogos de insulina n-glicosilados
|
|
CA2851521C
(en)
|
2011-10-14 |
2020-09-22 |
Amgen Inc. |
Injector and method of assembly
|
|
AU2013348071B2
(en)
|
2012-11-21 |
2018-05-24 |
Amgen Inc. |
Drug delivery device
|
|
CN105263319A
(zh)
|
2013-02-13 |
2016-01-20 |
法国化学与生物科技实验室 |
具有经修饰的糖基化的蛋白及其生产方法
|
|
BR112015019341A2
(pt)
|
2013-02-13 |
2017-08-22 |
Lab Francais Du Fractionnement |
Anticorpo anti-tnf-alfa, composição que compreende o anticorpo, método para produzir uma população de anticorpos, células epiteliais da glândula mamária, mamífero não humano transgênico, e, composição de anticorpo anti-tnf monoclonal
|
|
CA2901226C
(en)
|
2013-02-18 |
2020-11-17 |
Vegenics Pty Limited |
Vascular endothelial growth factor binding proteins
|
|
CA2904357C
(en)
|
2013-03-15 |
2020-09-22 |
Intrinsic Lifesciences Llc |
Anti-hepcidin antibodies and uses thereof
|
|
EP2968760B1
(de)
|
2013-03-15 |
2024-01-03 |
Amgen Inc. |
Medikamentenkassette, autoinjektor und autoinjektorsystem
|
|
WO2014143815A2
(en)
|
2013-03-15 |
2014-09-18 |
Amgen Inc. |
Drug cassette, autoinjector, and autoinjector system
|
|
TWI592183B
(zh)
|
2013-03-15 |
2017-07-21 |
安美基公司 |
本體輪廓可調適之自動注射器裝置
|
|
LT2976117T
(lt)
|
2013-03-22 |
2021-02-25 |
Amgen Inc. |
Purkštuvas ir surinkimo būdas
|
|
CA2916566A1
(fr)
|
2013-07-05 |
2015-01-08 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies |
Matrice de chromatographie d'affinite
|
|
EP3501575B1
(de)
|
2013-10-24 |
2021-12-01 |
Amgen Inc. |
Arzneimittelabgabesystem mit temperaturempfindlicher steuerung
|
|
BR112016008946B1
(pt)
|
2013-10-24 |
2022-12-27 |
Amgen Inc |
Injetores e método para montar os injetor
|
|
WO2015119906A1
(en)
|
2014-02-05 |
2015-08-13 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
|
EP3139977B1
(de)
|
2014-05-07 |
2021-02-17 |
Amgen Inc. |
Autoinjektor mit stossabsorbierenden elementen
|
|
SG11201609966SA
(en)
|
2014-06-03 |
2016-12-29 |
Amgen Inc |
Drug delivery system and method of use
|
|
US10323088B2
(en)
|
2014-09-22 |
2019-06-18 |
Intrinsic Lifesciences Llc |
Humanized anti-hepcidin antibodies and uses thereof
|
|
MX2021014323A
(es)
|
2014-10-14 |
2023-02-02 |
Amgen Inc |
Dispositivo de inyección de fármaco con indicadores visuales y audibles.
|
|
EP3848072A1
(de)
|
2014-12-19 |
2021-07-14 |
Amgen Inc. |
Medikamentenabgabevorrichtung mit näherungssensor
|
|
EP3689394A1
(de)
|
2014-12-19 |
2020-08-05 |
Amgen Inc. |
Arzneimittelabgabevorrichtung mit live-knopf oder benutzerschnittstellenfeld
|
|
EP3556411B1
(de)
|
2015-02-17 |
2021-06-30 |
Amgen Inc. |
Arzneimittelabgabevorrichtung mit vakuumunterstützter sicherung und/oder rückkopplung
|
|
EP3261690B1
(de)
|
2015-02-27 |
2021-12-15 |
Amgen Inc. |
Arzneimittelabgabevorrichtung mit nadelschutzmechanismus mit abstimmbarem widerstandsschwellwert gegenüber der bewegung des nadelschutzes
|
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
|
CA3002741A1
(en)
|
2015-10-23 |
2017-04-27 |
Apogenix Ag |
Single-chain gitr-receptor agonist proteins
|
|
US11351308B2
(en)
|
2015-12-09 |
2022-06-07 |
Amgen Inc. |
Auto-injector with signaling cap
|
|
WO2017120178A1
(en)
|
2016-01-06 |
2017-07-13 |
Amgen Inc. |
Auto-injector with signaling electronics
|
|
ES2814287T3
(es)
|
2016-03-15 |
2021-03-26 |
Amgen Inc |
Reducir la probabilidad de rotura de cristal en dispositivos de administración de fármaco
|
|
WO2017189089A1
(en)
|
2016-04-29 |
2017-11-02 |
Amgen Inc. |
Drug delivery device with messaging label
|
|
US11389588B2
(en)
|
2016-05-02 |
2022-07-19 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
|
WO2017197222A1
(en)
|
2016-05-13 |
2017-11-16 |
Amgen Inc. |
Vial sleeve assembly
|
|
WO2017200989A1
(en)
|
2016-05-16 |
2017-11-23 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
|
WO2017209899A1
(en)
|
2016-06-03 |
2017-12-07 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
|
EP3478342A1
(de)
|
2016-07-01 |
2019-05-08 |
Amgen Inc. |
Arzneimittelabgabevorrichtung mit minimiertem teilebruchrisiko nach aufprallereignissen
|
|
WO2018034784A1
(en)
|
2016-08-17 |
2018-02-22 |
Amgen Inc. |
Drug delivery device with placement detection
|
|
WO2018081234A1
(en)
|
2016-10-25 |
2018-05-03 |
Amgen Inc. |
On-body injector
|
|
AU2018210301A1
(en)
|
2017-01-17 |
2019-08-01 |
Amgen Inc. |
Injection devices and related methods of use and assembly
|
|
US11369736B2
(en)
|
2017-02-17 |
2022-06-28 |
Amgen Inc. |
Cannula insertion and retraction mechanisms
|
|
CA3048520A1
(en)
|
2017-02-17 |
2018-08-23 |
Amgen Inc. |
Drug delivery device with sterile fluid flowpath and related method of assembly
|
|
JP2020508803A
(ja)
|
2017-03-06 |
2020-03-26 |
アムジエン・インコーポレーテツド |
作動防止特徴部を備える薬物送達デバイス
|
|
SG11201908058UA
(en)
|
2017-03-07 |
2019-09-27 |
Amgen Inc |
Needle insertion by overpressure
|
|
KR102619150B1
(ko)
|
2017-03-09 |
2023-12-27 |
암겐 인코포레이티드 |
약물 전달 장치용 삽입 메커니즘
|
|
JP2020511499A
(ja)
|
2017-03-20 |
2020-04-16 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
赤血球生成刺激タンパク質のインビトロでの糖鎖改変のための方法
|
|
SI3600491T1
(sl)
|
2017-03-28 |
2023-11-30 |
Amgen Inc. |
Sistem in postopek za sestavljanja droga bata in brizge
|
|
CN110709121B
(zh)
|
2017-06-08 |
2022-06-24 |
安进公司 |
扭矩驱动式药物递送装置
|
|
AU2018280054B2
(en)
|
2017-06-08 |
2023-07-13 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
|
MX2019015472A
(es)
|
2017-06-22 |
2020-02-19 |
Amgen Inc |
Reduccion del impacto/choque de la activacion del mecanismo.
|
|
WO2018237225A1
(en)
|
2017-06-23 |
2018-12-27 |
Amgen Inc. |
ELECTRONIC DRUG DELIVERY DEVICE COMPRISING A CAP ACTIVATED BY A SWITCH ASSEMBLY
|
|
EP3651832B1
(de)
|
2017-07-14 |
2023-12-13 |
Amgen Inc. |
Nadeleinführ-retraktionssystem mit doppeltorsionsfedersystem
|
|
MA49626A
(fr)
|
2017-07-21 |
2020-05-27 |
Amgen Inc |
Élément d'étanchéité perméable aux gaz pour récipient à médicament et procédés d'assemblage
|
|
EP3658203B1
(de)
|
2017-07-25 |
2022-08-31 |
Amgen Inc. |
Arzneimittelabgabevorrichtung mit getriebemodul und verwandtes verfahren zur montage
|
|
MA49676A
(fr)
|
2017-07-25 |
2020-06-03 |
Amgen Inc |
Dispositif d'administration de médicament doté d'un système d'accès à un récipient et procédé d'assemblage associé
|
|
WO2019032482A2
(en)
|
2017-08-09 |
2019-02-14 |
Amgen Inc. |
HYDRAULIC-PNEUMATIC PRESSURE CHAMBER DELIVERY SYSTEM
|
|
EP3668567A1
(de)
|
2017-08-18 |
2020-06-24 |
Amgen Inc. |
Am körper tragbarer injektor mit sterilem klebepflaster
|
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
|
MA50611A
(fr)
|
2017-10-04 |
2020-08-12 |
Amgen Inc |
Adaptateur d'écoulement destiné à un dispositif d'administration de médicament
|
|
WO2019070552A1
(en)
|
2017-10-06 |
2019-04-11 |
Amgen Inc. |
DRUG DELIVERY DEVICE COMPRISING A LOCKOUT ASSEMBLY AND ASSOCIATED ASSEMBLY METHOD
|
|
US11464903B2
(en)
|
2017-10-09 |
2022-10-11 |
Amgen Inc. |
Drug delivery device with drive assembly and related method of assembly
|
|
MA50527A
(fr)
|
2017-11-03 |
2020-09-09 |
Amgen Inc |
Système et approches pour stériliser un dispositif d'administration de médicament
|
|
EP3706830B1
(de)
|
2017-11-06 |
2024-08-07 |
Amgen Inc. |
Arzneimittelabgabevorrichtung mit positionierungs- und durchflussmessung
|
|
EP3707075A1
(de)
|
2017-11-06 |
2020-09-16 |
Amgen Inc. |
Füllabschlussanordnungen und zugehörige verfahren
|
|
CN111225696B
(zh)
|
2017-11-10 |
2023-07-18 |
安进公司 |
用于药物递送装置的柱塞
|
|
AU2018368340B2
(en)
|
2017-11-16 |
2024-03-07 |
Amgen Inc. |
Door latch mechanism for drug delivery device
|
|
AU2018368338B2
(en)
|
2017-11-16 |
2024-07-25 |
Amgen Inc. |
Autoinjector with stall and end point detection
|
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
|
MA53379A
(fr)
|
2018-07-24 |
2021-06-02 |
Amgen Inc |
Dispositifs d'administration pour l'administration de médicaments
|
|
MA53375A
(fr)
|
2018-07-24 |
2021-06-02 |
Amgen Inc |
Dispositifs d'administration pour l'administration de médicaments
|
|
US12115360B2
(en)
|
2018-07-24 |
2024-10-15 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
|
WO2020023220A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with tacky skin attachment portion and related method of preparation
|
|
US12109389B2
(en)
|
2018-07-31 |
2024-10-08 |
Amgen Inc. |
Fluid path assembly for a drug delivery device
|
|
US20210346601A1
(en)
|
2018-09-24 |
2021-11-11 |
Amgen Inc. |
Interventional dosing systems and methods
|
|
AU2019350660B2
(en)
|
2018-09-28 |
2024-09-26 |
Amgen Inc. |
Muscle wire escapement activation assembly for a drug delivery device
|
|
CN117159846A
(zh)
|
2018-10-02 |
2023-12-05 |
安进公司 |
具有内部力传递的用于药物递送的注射系统
|
|
CA3112214A1
(en)
|
2018-10-05 |
2020-04-09 |
Amgen Inc. |
Drug delivery device having dose indicator
|
|
MX2021002791A
(es)
|
2018-10-15 |
2021-05-12 |
Amgen Inc |
Proceso de ensamblaje de plataforma para un dispositivo de administracion de farmacos.
|
|
MA53912A
(fr)
|
2018-10-15 |
2022-01-19 |
Amgen Inc |
Dispositif d'administration de médicament comprenant un mécanisme d'amortissement
|
|
US11213620B2
(en)
|
2018-11-01 |
2022-01-04 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
EP3873563A1
(de)
|
2018-11-01 |
2021-09-08 |
Amgen Inc. |
Vorrichtung zur verabreichung von medikamenten mit partiellem einzug des wirkstoffabgabeelements
|
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
|
CA3137360A1
(en)
|
2019-04-24 |
2020-10-29 |
Amgen Inc. |
Syringe sterilization verification assemblies and methods
|
|
WO2021041067A2
(en)
|
2019-08-23 |
2021-03-04 |
Amgen Inc. |
Drug delivery device with configurable needle shield engagement components and related methods
|
|
WO2022072718A1
(en)
|
2020-09-30 |
2022-04-07 |
Nobell Foods, Inc. |
Recombinant milk proteins and food compositions comprising the same
|
|
US10947552B1
(en)
|
2020-09-30 |
2021-03-16 |
Alpine Roads, Inc. |
Recombinant fusion proteins for producing milk proteins in plants
|
|
US10894812B1
(en)
|
2020-09-30 |
2021-01-19 |
Alpine Roads, Inc. |
Recombinant milk proteins
|
|
US20240208680A1
(en)
|
2021-05-21 |
2024-06-27 |
Amgen Inc. |
Method of optimizing a filling recipe for a drug container
|
|
WO2024094457A1
(en)
|
2022-11-02 |
2024-05-10 |
F. Hoffmann-La Roche Ag |
Method for producing glycoprotein compositions
|